Welcome!
Delfi Limited
Broker's Calls
CGS-CIMB ups Delfi's earnings estimates following record 9MFY2022 patmi
CGS-CIMB's analysts have, however, lowered their target price to $1.26 from $1.28 previously due to a lower P/E multiple of 15x.
November 18, 2022
Results
Delfi reports 539% y-o-y surge in patmi for 3QFY2022
Delfi says it has surpassed the performance of pre-Covid-19 periods, where patmi was US$5.9 million in 3QFY2019.
November 15, 2022
Results
Delfi reports 57.6% higher 1HFY2022 earnings of $19.4 mil
Delfi has declared an interim cash dividend of 1.58 US cents for the 1HFY2022, the highest paid since 2014.
August 11, 2022
Broker's Calls
CGS-CIMB is hungry for more of Delfi as it feeds consumer demands
CGS-CIMB Group Research has kept an “add” rating on Delfi with an unchanged target price of $1.09
April 12, 2022
Broker's Calls
Analysts remain positive on Delfi for FY2021
Analysts stay positive on Delfi Limited in lieu of strong showings for 2HFY2021 ended December
February 25, 2022
Broker's Calls
DBS ups Delfi’s TP to $1.07 as it sees 'worst quarter' as over
DBS Group Research analyst Chung Wei Le keeps “buy” on Delfi Limited., with an increased target price to $1.07.
November 23, 2021
SGX Research Series: 10 in 10
Delfi meets evergreen regional demand for sweet chocolate treats
Its portfolio of confectionery products includes global legacy brands and strong heritage national brands.
September 16, 2021
Broker's Calls
CGS-CIMB starts Delfi at 'add', expects sales momentum to grow beyond pre-Covid-19 levels
CGS-CIMB Research analyst Tay Wee Kuang has initiated “add” on chocolate confectionery company Delfi
September 13, 2021
Broker's Calls
DBS ups Delfi's TP to $1.06 on cautious optimism for FY2022
To DBS, Delfi’s valuation is inexpensive at 12.6 times FY2022 P/E, which is -1.5 s.d. of its four-year historical mean.
August 16, 2021